This book provides guidelines to national TB program managers, policy makers, nongovernmental organizations, and donor agencies on effective management of TB. The guidelines focus on the technical and managerial aspects of treatment.
This tool estimates the risk of active tuberculosis for an individual with a tuberculin skin test reaction of 5+mm, based on his/her clinical profile. It is intended for adults tested with standard tuberculin (5 TU PPDS, or 2 TU RT-23).
Popularly known as “The Orange Guide”, the 6th edition of this small book provides practical guidance to health workers on the front line of TB control. It includes sections on HIV, MDR-TB and a review of the recommended treatment regimens.
The Truth About TB website is part of a new campaign to get people talking and thinking about TB. The campaign is being developed by TB Alert, the UK's national Tuberculosis charity. The website includes stories by people who have been affected by TB, questions and answers about TB, and a variety of resources.
This new report on anti-tuberculosis (TB) drug resistance by the World Health Organization (WHO) updates “Anti-tuberculosis drug resistance in the world: Report No. 4” published by WHO in 2008. It summarizes the latest data and provides latest estimates of the global epidemic of multidrug and extensively drug-resistant tuberculosis (M/XDR-TB). For the first time, this report includes an assessment of the progress countries are making to diagnose and treat MDR-TB cases.
The Southeastern National Tuberculosis Center in collaboration with the Lung Health Center at the University of Alabama at Birmingham developed TB-specific cultural competency guides. These guides have been adapted into a series of “quick reference guides.” There are quick reference guides for the countries that have accounted for more than 60% of the TB cases among foreign-born persons over the past five years: Mexico, the Philippines, India, Vietnam, China, Guatemala, and Haiti.
The ILO and WHO, with the help of other partners in the world of work, have collaborated to develop international guidelines of TB management at the workplace. These outline how any business, large or small, or public sector workplace can make a contribution to TB management and control.
This report provides guidance to U.S. public health officials, health-care providers, and laboratory workers for use of FDA-approved IGRAs in the diagnosis of M. tuberculosis infection in adults and children. In brief, TSTs and IGRAs (QFT-G, QFT-GIT, and T-Spot) may be used as aids in diagnosing M. tuberculosis infection. They may be used for surveillance purposes and to identify persons likely to benefit from treatment. Multiple additional recommendations are provided that address quality control, test selection, and medical management after testing.
This fact sheet provides guidance to health-care providers for use of IGRAs in the diagnosis of M. tuberculosis infection in adults and children.
This slide set was developed as an accompaniment to the guidelines Prevention and Control of Tuberculosis in Correctional and Detention Facilities: Recommendations from CDC.
